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ABSTRACT The majority of emerging zoonoses originate in wildlife, and many are caused by viruses. However, there are no rigor-
ous estimates of total viral diversity (here termed “virodiversity”) for any wildlife species, despite the utility of this to future sur-
veillance and control of emerging zoonoses. In this case study, we repeatedly sampled a mammalian wildlife host known to har-
bor emerging zoonotic pathogens (the Indian Flying Fox, Pteropus giganteus) and used PCR with degenerate viral family-level
primers to discover and analyze the occurrence patterns of 55 viruses from nine viral families. We then adapted statistical tech-
niques used to estimate biodiversity in vertebrates and plants and estimated the total viral richness of these nine families in P. gi-
ganteus to be 58 viruses. Our analyses demonstrate proof-of-concept of a strategy for estimating viral richness and provide the
first statistically supported estimate of the number of undiscovered viruses in a mammalian host. We used a simple extrapola-
tion to estimate that there are a minimum of 320,000 mammalian viruses awaiting discovery within these nine families, assum-
ing all species harbor a similar number of viruses, with minimal turnover between host species. We estimate the cost of discover-
ing these viruses to be ~$6.3 billion (or ~$1.4 billion for 85% of the total diversity), which if annualized over a 10-year study time
frame would represent a small fraction of the cost of many pandemic zoonoses.
IMPORTANCE Recent years have seen a dramatic increase in viral discovery efforts. However, most lack rigorous systematic de-
sign, which limits our ability to understand viral diversity and its ecological drivers and reduces their value to public health in-
tervention. Here, we present a new framework for the discovery of novel viruses in wildlife and use it to make the first-ever esti-
mate of the number of viruses that exist in a mammalian host. As pathogens continue to emerge from wildlife, this estimate
allows us to put preliminary bounds around the potential size of the total zoonotic pool and facilitates a better understanding of
where best to allocate resources for the subsequent discovery of global viral diversity.
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The majority of emerging infectious diseases (EIDs) of hu-mans are zoonoses, and the majority of these originate in
wildlife (1–3). These diseases are largely viral (e.g., severe acute
respiratory syndrome [SARS] and Nipah virus) and represent a
significant global health threat. Analyses of trends in EIDs sug-
gest that the rate of infectious disease emergence is increasing
(3) and that the emergence of new viruses is not yet constrained
by the richness (number of viruses) or diversity (genetic vari-
ability) of unknown viruses in wildlife, which is thought to be
high. Systematically measuring viral richness, abundance, and
diversity (here termed “virodiversity”) in wildlife is hindered
by the large number of host species (e.g., around 5,500 mam-
mals), their global distribution and often remote habitats (4),
and the expense of collection, sampling, and viral identification
or discovery (5), and it has not yet been achieved for even a
single host species. In this study, we repeatedly sampled a
mammalian host known to harbor emerging zoonotic patho-
gens (the Indian Flying Fox, Pteropus giganteus) and used PCR
with degenerate primers targeting nine viral families to dis-
cover a large number and diversity of viruses. We then adapted
the techniques normally used to estimate biodiversity in verte-
brates and plants to estimate the total viral richness within
these nine families in P. giganteus. Our analyses demonstrate
proof-of-concept and provide the first statistically supported
estimates of the unknown viral richness of a mammalian host
and the sampling effort required to achieve it.
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RESULTS
Viral discovery. A total of 12,793 consensus PCR assays were per-
formed for the detection of viruses from nine different families/
genera, including coronaviruses (CoVs; n 1,631), paramyxovi-
ruses (PMVs; n  1,108), hantaviruses (HTVs; n  1,108),
astroviruses (AstVs; n 1,348), influenza A viruses (IFAVs; n
1,108), bocaviruses (BoVs; n  1,739), adenoviruses (AdVs; n 
1,902), herpesviruses (HVs; n  1,741), and polyomaviruses
(PyVs; n 1,108) (Table 1). None of the samples were positive for
IFAVs or HTVs, despite previous studies documenting their pres-
ence in other bat species (6–8); however, a total of 985 viral se-
quences representing the other seven viral families were detected
in these bats. These sequences were segregated into 55 discrete
viruses based on distinct monophyletic clustering (see Materials
and Methods) (Table 1), and a virus was considered novel if the
sequence identity to its closest relative was less than or equal to the
identity between the two closest species for a given viral family (9).
Eleven PMVs were detected, including 10 novel viruses
(PMV-1 from P. giganteus [PgPMV-1] to PgPMV-10) and Nipah
virus (PgPMV-11). These PMVs exhibited high sequence varia-
tion and clustered phylogenetically with either the rubulaviruses
or an unassigned group related to the henipaviruses (Fig. 1).
Within the AdV family, 14 viruses were discovered (PgAdV-1 to
-14). Thirteen were novel mastadenoviruses, while one virus
(PgAdV-2) had 98% nucleotide identity to the aviadenovirus Fowl
adenovirus E (Fig. 2). Eight different AstVs were found (PgAstV-1
to -8), all of which were novel and clustered within the genus
Mamastrovirus (Fig. 3). Within the CoV family, four distinct vi-
ruses were discovered. The first two were closely related betacoro-
naviruses (PgCoV-1 and -2). The third was also a betacoronavirus
(PgCoV-3) but was more distantly related and showed 97% nu-
cleotide identity to bovine and human coronaviruses (human
strains 4408 and OC43). The fourth CoV was a gammacoronavi-
rus (PgCoV-4) with 91% nucleotide identity (97% at the amino
acid level) to the avian Infectious bronchitis virus (Fig. 4). Three
novel PyVs were identified (PgPyV-1 to -3), all of which clustered
with viruses in the genusOrthopolyomavirus (Fig. 5). A total of 639
HV sequences were detected, which segregated into 13 distinct
clades (PgHV 1 to 13) using hierarchical clustering (see Materials
and Methods). None could be reliably classified within any exist-
ing genus, and they likely represent new groups within the Beta-
herpesvirinae and Gammaherpesvirinae subfamilies (Fig. 6). One
virus, PgHV-11, appears to be a recombinant between PgHV-10
and PgHV-13, with a breakpoint evident at approximately nucle-
otide 90. Upstream from this breakpoint, the sequences for
PgHV-11 are related to PgHV-10, while downstream from the
breakpoint, they are related to PgHV-13. Finally, two different
BoVs were discovered (PgBoV-1 and -2), both of which showed
98% nucleotide identity to known human BoVs (Fig. 7).
Viral discovery curves and estimates of viral richness. As-
ymptotic viral richness was estimated from observed detections
using three statistical models, Chao2, ICE, and Jackknife (10). To
ensure internal consistency, only those samples screened for the
full complement of nine viral families/genera were included (n
1,092), which accounted for 44/55 viruses identified in this study.
The relative frequency of these viruses is presented in Fig. S1 in the
supplemental material. Of the 1,092 samples included, 766 were
negative for all viruses. There were 595 viral detections from 326
positive samples, with 167 samples containing1 virus. When all
44 viruses were considered, the accumulative discovery curve be-
gan to show signs of saturation (Fig. 8). The Chao2 estimator
demonstrated asymptotic behavior as early as 500 samples (50%
of tested samples) and was highly stable (low variance) by 1,000
samples (Fig. 8). The total viral richness within our sample popu-
lation was estimated to be 58 viruses (limited to viral families
tested for), and the required sampling effort to discover all 58 was
estimated to be 7,079 samples. Asymptotic estimates of viral rich-
ness were also calculated individually for PMVs, AstVs, HVs, and
AdVs (see Fig. S2 in the supplemental material). For HVs, AstVs,
and PMVs, estimates were stable or stabilizing and showed that
most of the predicted viral diversity had been identified. For AdVs,
none of the estimators stabilized, probably due to a high
singleton-to-doubleton ratio (i.e., the rate of discovery of new
viruses was still high). Individual assessments were not performed
for CoVs, PyVs, or BoVs because a lack of single or double detec-
tions prevented meaningful estimates (10).
Coinfection. Positive PCR products were cloned and se-
quenced to look for the presence of cooccurring viruses. A total of
276 samples contained1 virus, including urine (n 56), throat
swabs (n 199), and roost urine (n 56). Between 2 and 5 viruses
were found to coexist, and both intrafamilial (n  223/276) and
interfamilial (n  93/276) viral family cooccurrences were ob-
served (Fig. 9). Intraspecific codetections were limited to the fam-
ilies Herpesviridae and Adenoviridae (Fig. 9 and see Table S1 in the
supplemental material). The patterns of HV cooccurrence were
significantly nonrandom (P0.001 with C score [11, 12]), and
positive pairwise associations were observed between PgHV-13
and PgHV-10 and between PgHV-11 and PgHV-10 (P0.001).
A negative association was also observed between PgHV-13 and
-12, where the observed frequency of cooccurrence was below
what would be expected by chance, given the prevalence of both
viruses (P0.001). The patterns of cooccurrence for different
adenoviruses were less structured, and no robustly supported pos-
itive or negative associations were observed. The same is true for
analyses of interfamilial codetections.
DISCUSSION
In this study, we combined virological and ecological techniques
to describe the virodiversity of a known zoonotic reservoir, P. gi-
ganteus, including the first-ever estimate of viral richness and the
sampling effort required to detect any proportion of it. The article
also includes a phylogenetic description of 55 viruses identified in
this species and an ecological description of the positive and neg-
ative occurrences between them. This unprecedented description
of the potential zoonotic pool not only establishes a framework for
comparison of virodiversity among host populations in different
geographic regions and ecological settings but also provides im-
portant a priori knowledge should a novel pathogen emerge or
have emerged. For example, sequence data from this study are
already being used to develop serological assays to test people with
a range of symptoms and known high risk of exposure to bats. This
will allow us to identify cases of bat-to-human viral spillover and,
potentially, their health consequences.
Estimate of total viral diversity (richness) in P. giganteus in
Bangladesh. Previous attempts have been made to predict the
total number of unknown viruses in humans by analyzing tempo-
ral trends in viral discovery (13, 14). However, these assessments
principally consider the emergence of disease-causing agents
rather than an ecological assessment of virodiversity. Here, we
Anthony et al.
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TABLE 1 Summary of viral discovery performed on P. giganteus
Virus
No. of samples PCR positive/no. testeda
Urine Throat Feces Roost urine Total
Herpesvirus
PgHV-1 9/926 29/711 0/78 0/26 38/1,741
PgHV-2 4/926 9/711 0/78 0/26 13/1,741
PgHV-3 1/926 0/711 0/78 0/26 1/1,741
PgHV-4 9/926 21/711 0/78 0/26 30/1,741
PgHV-5 1/926 0/711 0/78 1/26 2/1,741
PgHV-6 1/926 0/711 0/78 0/26 1/1,741
PgHV-7 2/926 8/711 0/78 0/26 10/1,741
PgHV-8 23/926 157/711 0/78 0/26 180/1,741
PgHV-9 0/926 3/711 0/78 0/26 3/1,741
PgHV-10 15/926 68/711 0/78 0/26 83/1,741
PgHV-11 0/926 4/711 0/78 0/26 4/1,741
PgHV-12 10/926 99/711 0/78 0/26 109/1,741
PgHV-13 6/926 159/711 0/78 0/26 165/1,741
Total 81/926 557/711 0/78 1/26
Paramyxovirus
PgPMV-1 1/598 0/510 NTb NT 1/1,108
PgPMV-2 2/598 0/510 NT NT 2/1,108
PgPMV-3 0/598 2/510 NT NT 2/1,108
PgPMV-4 0/598 1/510 NT NT 1/1,108
PgPMV-5 0/598 3/510 NT NT 3/1,108
PgPMV-6 1/598 7/510 NT NT 8/1,108
PgPMV-7 0/598 2/510 NT NT 2/1,108
PgPMV-8 1/598 0/510 NT NT 1/1,108
PgPMV-9 2/598 0/510 NT NT 2/1,108
PgPMV-10 1/598 1/510 NT NT 2/1,108
PgPMV-11 (NiV) 1/598 2/510 NT NT 3/1,108
Total 9/598 18/510
Polyomavirus
PgPyV-1 1/598 0/510 NT NT 1/1,108
PgPyV-2 0/598 3/510 NT NT 3/1,108
PgPyV-3 3/598 1/510 NT NT 4/1,108
Total 4/598 4/510
Coronavirus
PgCoV-1 8/816 1/745 NT 5/70 14/1,631
PgCoV-2 33/816 10/745 NT 17/70 60/1,631
PgCoV-3 (bovine/human-like) 1/816 0/745 NT 0/70 1/1,631
PgCoV-4 (avian IBV-like) 0/816 1/745 NT 0/70 1/1,631
Total 42/816 12/745 22/70
Adenovirus
PgAdV-1 1/931 0/806 0/78 0/87 1/1,902
PgAdV-2 (avian AdV) 1/931 0/806 0/78 0/87 1/1,902
PgAdV-3 4/931 4/806 0/78 0/87 8/1,902
PgAdV-4 0/931 1/806 0/78 0/87 1/1,902
PgAdV-5 34/931 16/806 0/78 3/87 53/1,902
PgAdV-6 0/931 2/806 0/78 0/87 2/1,902
PgAdV-7 11/931 1/806 0/78 1/87 13/1,902
PgAdV-8 17/931 2/806 0/78 0/87 19/1,902
PgAdV-9 5/931 1/806 0/78 2/87 8/1,902
PgAdV-10 1/931 0/806 0/78 0/87 1/1,902
PgAdV-11 4/931 0/806 0/78 0/87 4/1,902
PgAdV-12 1/931 0/806 0/78 0/87 1/1,902
(Continued on following page)
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measured viral richness using nonparametric species discovery
curves, which are commonly used in biodiversity studies (10, 13,
15–17) and rely on the frequency of rarely occurring species to
measure the completeness of discovery (15) and make statistical
estimations of the undiscovered fraction (10). Our estimate of the
viral carrying capacity of P. giganteus as 58 viruses (for the nine
viral families assayed) was robustly supported, with the cumula-
tive number of new viruses slowing toward an asymptotic trajec-
tory and with statistical estimators showing reliably asymptotic
behavior. Given that our total discovery effort revealed 55 of the
estimated 58 viruses, we suggest that most have now been identi-
fied and that the remaining viruses in P. giganteus in Bangladesh
are extremely rare. However, we make the qualification that this
estimation of richness is likely a minimum and that additional
viruses will almost certainly be found through the expansion of
viral family testing and the use of high-throughput sequencing.
While we cannot infer a great deal about the biology or taxo-
nomic relatedness of the undiscovered diversity, our estimate of
viral richness does allow useful considerations of the efficacy of
viral discovery efforts in this species. In general, surveys for undis-
covered diversity present diminishing returns, since the com-
monly occurring species are quickly identified, while the rare spe-
cies require an increasingly large sampling effort. Here, the Chao 2
estimator predicted that 85% of the total richness could be
achieved if another ~500 samples were screened but that a further
~5,500 would then be required to find the remaining 15%. Con-
sidering that only very rare viruses would exist within this final
fraction and assuming that this rarity reduces both exposure and
the chance of transmission, the public health advantage gained by
knowledge of their biological properties or taxonomy may not be
sufficiently high to justify the cost of their discovery. Similar esti-
mations were made for each of the viral families individually. For
example, 13 HVs were discovered in a total of 1,741 samples, with
an estimated 8,503 additional samples needed to identify just 2
more predicted viruses (100% of the estimated). Equally, 11
PMVs were identified in 1,108 samples, with one additional virus
projected from a further 773 samples. In both cases, an extremely
limited return is expected from a costly discovery effort.
Estimates of unknown viral diversity (richness) in all mam-
mals and the cost of discovery. Mammals are the reservoir hosts
of the majority of emerging zoonoses (2, 3, 18). If we assume that
all 5,486 described mammalian species (19) harbor an average of
58 viruses in the nine families of interest (as estimated here in
P. giganteus) and that these viruses exhibit 100% host specificity,
the total richness of mammalian viruses awaiting discovery ex-
ceeds ~320,000. We used the data on expenditures for surveillance
and pathogen discovery in this study to calculate the direct cost of
discovering all 58 viruses in P. giganteus (see the supplemental
material for details of this cost analysis). We estimate this cost to
be $1.2 million, including collection and laboratory testing of
7,079 samples. Assuming expenditures to be equal for all host
species, the cost of sampling and viral discovery for all mammalian
viruses would be approximately $6.3 billion. Accounting for di-
minishing returns means that discovering 85% of the estimated
diversity would be disproportionately cheaper at approximately
$1.4 billion. Our estimates of virodiversity and cost of discovery
are preliminary; however, we include them to demonstrate (i)
how a systematic estimation of total viral diversity could be used
to inform better surveillance through strategic resource allocation
and (ii) that, given our cost estimates, the discovery of the major-
ity of potential zoonotic viruses is not an unattainable goal over
the next few decades. The generation of sequence data will not, of
course, in itself prevent pandemics. However, it does provide data
that refine our knowledge of the functional relationship between
host and viral diversity, including traits associated with increased
risk of spillover and subsequent emergence (e.g., viruses closely
TABLE 1 (Continued)
Virus
No. of samples PCR positive/no. testeda
Urine Throat Feces Roost urine Total
PgAdV-13 22/931 3/806 0/78 6/87 31/1,902
PgAdV-14 38/931 11/806 0/78 5/87 54/1,902
Total 139/931 41/806 0/78 17/87
Astrovirus
PgAstV-1 0/696 1/585 NT 1/67 2/1,348
PgAstV-2 1/696 0/585 NT 0/67 1/1,348
PgAstV-3 3/696 0/585 NT 8/67 11/1,348
PgAstV-4 0/696 0/585 NT 2/67 2/1,348
PgAstV-5 0/696 0/585 NT 3/67 3/1,348
PgAstV-6 0/696 0/585 NT 1/67 1/1,348
PgAstV-7 1/696 0/585 NT 0/67 1/1,348
PgAstV-8 0/696 0/585 NT 15/67 15/1,348
Total 5/696 1/585 30/67
Bocavirus
PgBoV-1 (human BoV) 1/925 0/710 0/78 0/26 1/1,739
PgBoV-2 (human BoV) 0/925 1/710 0/78 0/26 1/1,739
Total 1/925 1/710 0/78 0/26
a A total of 55 viruses from seven viral families were discovered. The discovery effort (number of samples tested) and prevalence of each virus is presented.
b NT, not tested.
Anthony et al.
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related to and sharing receptor binding domains with known le-
thal agents [20]) and, also, facilitates the development of rapid
diagnostic tests for intervention and control.
Several important limitations must be considered in our ex-
trapolations, including (i) the assumption that a mean of 58 vi-
ruses per species is a reasonable estimate and that host populations
are panmictic with respect to viral transmission (such that ex-
panded geographic sampling would not influence viral detec-
tions), (ii) the assumption that viruses are not shared by more
than one host species, (iii) that only those viruses within the nine
families are considered in this estimation, (iv) that the results are
limited by the sensitivity and specificity of our tests, and (v) that a
similar mean cost of sample collection is incurred across all spe-
cies. Clearly, many of these limitations and assumptions require
additional exploration. For example, while including more viral
families in our survey would increase the viral richness estimate,
FIG 1 Phylogenetic tree (ML) of PMV large gene (RdRp). Alignment length, 534 bp of nucleotide sequence. PgPMV-1 to -10 were discovered in this study.
PgPMV-11 is Nipah virus. The number of samples that tested positive for each respective virus in urine (U) and throat (T) is indicated in parentheses. *, published
bat PMV sequences. Novel viruses detected in this study are identified with the prefix Pg (Pteropus giganteus) and were assigned accession numbers KC692403
to KC692412
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FIG 2 Phylogenetic tree (ML) of AdV polymerase. Alignment length, 301 bp of nucleotide sequence. PgAdV-1 to -14 were discovered in this study. The number
of samples that tested positive for each respective virus in urine (U), throat (T), feces (F), and roost urine (RU) is indicated in parentheses. *, published bat AdV
sequences. Viruses detected in this study are identified with the prefix Pg (Pteropus giganteus) and were assigned accession numbers KC692417 to KC692430
Anthony et al.
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accounting for species turnover (viral sharing between species)
would reduce it. Also, while the cost of sample collection in Ban-
gladesh is relatively low because of logistical simplicities, in some
regions (e.g., tropical montane forests of Africa and Southeast
Asia), the cost of transportation is much higher. Better estimates
of the total number of viruses in mammals (and the cost of their
discovery) will be achieved iteratively as other hosts are more ex-
tensively sampled and tested, additional viral families are in-
cluded, and the limits of viral detection increase.
Novel viruses. The current study significantly enhances our
knowledge of the viruses harbored by P. giganteus, for which only
two viruses had been previously described, Nipah virus and a GB
virus-like flavivirus (21, 22). A total of 50/55 of the viruses discov-
ered in this study were considered novel, while 5/55 have been
reported previously (PgBoV-1 and -2, PgCoV-3 and -4, and
PgPMV-11). Additional discussion of the 50 novel viruses is pro-
vided in the supplemental material. Here, we discuss a number of
important limitations that must be considered in the interpreta-
FIG 3 Phylogenetic tree (ML) of AstV RdRp. Alignment length, 320 bp of nucleotide sequence. PgAstV-1 to -8 were discovered in this study. The number of
samples that tested positive for each respective virus in urine (U), throat (T), and roost urine (RU) is indicated in parentheses. *, published bat AstV sequences.
Viruses detected in this study are identified with the prefix Pg (Pteropus giganteus) and were assigned accession numbers KC692431 to KC692437
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FIG 4 Phylogenetic tree (ML) of CoV RdRp. Alignment length, 310 bp of nucleotide sequence. PgCoV-1 to -4 were discovered in this study. The number of
samples that tested positive for each respective virus in urine (U), throat (T), and roost urine (RU) is indicated in parentheses. *, published bat CoV sequences.
Bat coronaviruses cluster based on the host family (indicated). ~, HKU2 seems anomalously positioned as it was detected in Rhinolophus sinicus, which is
unrelated to bats from the families Vespertilionidae or Molossidae. The reason for this is unknown. Viruses detected in this study are identified with the prefix Pg
(Pteropus giganteus), and were assigned accession numbers KC692413 to KC692416. IBV, infectious bronchitis virus; MHV, mouse hepatitis virus; PHEV,
porcine hemagglutinating encephalomyelitis virus; HCoV, human CoV; BtCoV, bat CoV; FIPV, feline infectious peritonitis virus; TGEV, transmissible gastro-
enteritis coronavirus; PEDV, porcine epidemic diarrhea virus.
Anthony et al.
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tion of these results. First, the use of consensus PCR limits surveil-
lance and discovery to viruses related to those targeted in these
assays. Second, variations in virus concentration can also influ-
ence the probability of detection. Third, we evaluated the diversity
of viruses in a limited set of compartments and tissues, and unbi-
ased sequencing was not used as a secondary method of capturing
diversity. The classification of viruses is also significant, as rede-
fining the genetic limits between one virus and another would
change the total number and prevalence of viruses discovered and
would impact our estimations of viral richness. We have tried to
address this by using monophyletic clades as a taxonomic surro-
gate, which obviates the variable and polythetic criteria set by the
ICTV for species demarcations.
Coinfection. The identification of coexisting microbes is im-
portant to a description of virodiversity because of the positive
and negative associations that can occur between them (23–28).
Here, we report a large number of intra- and interfamilial cooc-
currences in P. giganteus and show that as many as five different
FIG5 Phylogenetic tree (ML) of PyV VP1 (major capsid protein). Alignment length, 320 bp of nucleotide sequence. PgPyV-1 to -3 were discovered in this study.
The number of samples that tested positive for each respective virus in urine (U) and throat (T) is indicated in parentheses. *, published bat PyV sequences.
Viruses detected in this study are identified with the prefix Pg (Pteropus giganteus) and were assigned accession numbers KC692400 to KC692402.
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viruses can exist in a single sample. Not only does this reveal in-
formation about the carrying capacity and composition of discrete
viral niches within an individual bat, it also demonstrates the
number of different viruses that could potentially spill over to a
new host from a single exposure event.
The most common intrafamilial codetections were observed
within the subfamily Herpesviridae, supporting previous studies
demonstrating coinfection of HVs in bats (29). Statistically sup-
ported associations were observed between PgHV-10, -11, and
-13, which phylogenetically cluster within a presumptive new ge-
nus of the betaherpesvirus subfamily. It is not known whether
these detections represent coinfection of the same cell or a group
FIG 6 Phylogenetic tree (ML) of HV polymerase. Alignment length, 211 bp of nucleotide sequence. PgHV-1 to -13 were discovered in this study. The number
of samples that tested positive for each respective virus in urine (U), throat (T), feces (F), and roost urine (RU) is indicated in parentheses. *, published bat HV
sequences. Viruses detected in this study are identified with the prefix Pg (Pteropus giganteus) and were assigned accession numbers KC692438 to KC692450.
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of viral variants with segregated cell tropism. It is also unknown
why these viruses should so readily coexist, though ecological
mechanisms such as simultaneous transmission (codispersal), the
availability of requisite resources, and/or shared benefits associ-
ated with host immunomodulation by one or more of these vi-
ruses may explain the observed cooccurrence. Recombination is
also a possible consequence of coinfection and is a common fea-
ture in the ecology and evolution of herpesviruses (30–36).
PgHV-11 was identified as a recombinant lineage derived from the
strongly associated PgHV-10 and PgHV-13, and all three viruses
FIG 7 Phylogenetic tree (ML) of BoV NS1. Alignment length, 287 bp of nucleotide sequence. PgBoV-1 and -2 were detected in this study. The number of
samples that tested positive for each respective virus in urine (U), throat (T), feces (F), and roost urine (RU) is indicated in parentheses. Viruses detected in this
study are identified with the prefix Pg (Pteropus giganteus) and were assigned accession numbers KC692451 to KC692452.
FIG 8 Viral discovery curve. A subset of 1,092 samples were tested for all nine viral families, and 44 viruses (out of a total of 55) are represented. The 11 viruses
not considered were PgHV-2, -5, -6, and -9; PgAdV-1 and -10, PgAstV-4, -5, -6, and -8, and PgBoV-1. Black line, the rarefaction curve; red line, collector curve
showing accumulation of novel viruses over samples tested; blue line, Chao2 estimator at every sample point, with arrow indicating 95% confidence intervals;
gray lines, ICE and Jackknife estimators at every sample point; dashed vertical lines, required sampling effort to discover an arbitrary proportion of the total
diversity (including 100%); horizontal line, total estimated diversity, 58 viruses, and effort required to discover 100% of the estimated diversity, 7,079 samples.
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were detected in the same sample or compartment (throat) mul-
tiple times, suggesting that true coinfection does occur, albeit with
unknown frequency.
A negative association was also observed between PgHV-12
and -13, suggesting that mechanisms might also exist to reduce
cooccurrence. These two viruses are very closely related, and we
speculate that cooccurrence may offer little benefit to the viral
population because of increased competition for resources cou-
pled with minimal potential for fitness gains via recombination.
Even though previous studies showed a lack of immune recogni-
tion in betaherpesviruses (37), we suggest this might act as an
effective mechanism for reducing the coexistence of closely related
viruses by preventing sequential infections. Such a mechanism
would not completely preclude cooccurrence due to codispersal
and would therefore serve to explain why some codetections were
still observed between these two viruses.
Viral spillover. Our discovery efforts revealed five viruses that
appear to represent spillover events. These included two human
bocaviruses (PgBoV-1 and -2), an avian adenovirus (PgAdV-2), a
human/bovine betacoronavirus (PgCoV-3), and an avian gam-
macoronavirus (PgCoV-4). In each case, these viruses were only
observed once and showed strong phylogenetic association to vi-
ruses found in humans, birds, or ruminants. The interface by
which these viruses were able to move from these disparate hosts
into bats is unclear. However, on several occasions, we have ob-
served P. giganteus in Bangladesh drinking from bodies of water
(rivers and ponds) that are used by people, livestock, domestic
animals, and wildlife for drinking, bathing, and in some cases,
sewage, and we hypothesize that shared water sources may be a
source of exposure. Viral spillover (and/or host switching) is an
example for which the concept of virodiversity in defined animal
host populations might be particularly important. Such processes
precede many emergence events (3, 38); however, there is almost
certainly additional asymptomatic movement of viruses between
hosts, the frequency and impact of which remain poorly under-
stood.
An additional consideration is that any of the 55 viruses found
in P. giganteus may have already spilled over into the human pop-
ulation. Annual outbreaks of Nipah virus in Bangladesh demon-
strate that human exposure to viruses from these bats persists
(39–44), and there are a significant number of undiagnosed mor-
bidities and mortalities in this region that may well have resulted
from the spillover of one of these other viruses. Subclinical move-
ment is equally possible, as demonstrated with Tioman virus in
Malaysia (45, 46), and investigating these spillover events may
help to refine our understanding of disease emergence in novel
hosts.
Conclusions. Our work illustrates the power of using ecologi-
cal approaches to characterize virodiversity and estimate viral
richness and can be considered part of a strategy to better target
surveillance to identify agents that pose zoonotic risks before they
emerge in people (3). The projected $1.4 billion cost of discover-
ing 85% of the estimated diversity is far less than the economic
impact of even a single pandemic like SARS, which has been esti-
mated at $16 Billion (47). If annualized over a 10-year period, the
discovery of 85% of mammalian viral diversity would be just $140
million/year, which is both a one-off cost and a fraction of the cost
of globally coordinated pandemic control programs such as the
“One World, One Health” program, estimated at $1.9 to 3.4 bil-
lion per year, recurring (64). While these programs will not them-
FIG 9 Coinfection matrix of the 55 viruses identified or discovered in P. giganteus. Heat map of coinfections is presented in lower left section. Data used to
generate the heat map (numbers of pairwise incidences) are presented in upper right section.
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selves prevent the emergence of new zoonotic viruses, they will
further contribute to pandemic preparedness by enhancing our
understanding of viral ecology and the mechanisms of disease
emergence and by providing sequences and other insights that
reduce the morbidity, mortality, and economic impact of emerg-
ing infectious diseases by expediting recognition and interven-
tion.
MATERIALS AND METHODS
Samples and PCR screening. Samples (n  1,897) were collected from
apparently healthy P. giganteus bats throughout Bangladesh between 2006
and 2010, as described previously (48). This included urine (n  926),
throat swabs (n  806), feces (n  78), and roost urine (n  97). All
samples were collected by trained veterinarians, and all animals were re-
leased unharmed. Samples were collected directly into lysis buffer (bio-
Mérieux, Inc.) and stored at80°C until transfer to the Center for Infec-
tion and Immunity at Columbia University. Roost urine samples were
also obtained by suspending 3- by 2-m polyethylene sheets underneath
roosting colonies, which collected urine (with possible fecal contamina-
tion) from the bats roosting above. Total nucleic acid was extracted from
all samples using the EasyMag (bioMérieux, Inc.) platform, and cDNA
synthesis performed using SuperScript III first-strand synthesis supermix
(Invitrogen), all according to the manufacturer’s instructions. Viral dis-
covery was performed using broadly reactive consensus PCR assays tar-
geting coronaviruses (49), paramyxoviruses (50), astroviruses (51), influ-
enza A viruses (38), adenoviruses (52), polyomaviruses (53), bocaviruses
(54), and herpesviruses (55). Consensus primers for hantaviruses were
modified from an existing protocol (56) in order to increase the degener-
acy of the assay, and the assay validated for its ability to detect diverse
hantaviruses, including Andes, Puumala, Sin Nombre, Prospect Hill,
Seoul, and Thottapalayam hantaviruses. The modified primer sequences
were UHantaF1 (GWGGVCARACWGCHGAYT) and UHantaR1 (CCW
GGTGTDADYTCHTCWGC) (expected amplicon, 250 bp), and the an-
nealing temperature was 52°C. All PCR products of the expected size were
cloned into Strataclone PCR cloning vector, and 12 white colonies se-
quenced using standard M13R primers.
Trace sequences were analyzed and edited using Geneious (version
6.0.3). Sequences were aligned with ClustalW and MUSCLE, and phylo-
genetic trees constructed with neighbor-joining (p-distance, pairwise de-
letion, 1,000 bootstraps), maximum-likelihood (1,000 bootstraps), and
Bayesian (Mr Bayes) algorithms. Models of evolution were selected using
ModelTest, and a tree representing a consensus of the different methods is
presented. Sequence identity (p-distance, pairwise deletion) was calcu-
lated in Mega 5.
Virus classification. For the purposes of this study, we avoided the use
of taxonomic concepts such as species or genotype because of the variable
criteria used for such distinctions (9) and because the degree of sequence
conservation used to establish such distinctions can vary across the ge-
nome and may be affected by the relatively short sequence fragments
generated in this study. We focused instead on collections of viral se-
quences that form distinct monophyletic clades within a particular family,
and we considered a virus novel if the sequence identity to its closest
relative is less than or equal to the identity between the two closest species
for a given viral family. Due to the very large number of herpesvirus
sequences identified in this study (n 650), we used hierarchical cluster-
ing to segregate sequences for this particular family. To do this, we first
extracted 598 polymerase sequences from published complete genomes
(downloaded from NCBI on 14 September 2012) and combined them
with the sequences generated in this study (total of 1,248 sequences).
Coding sequences were translated and aligned using MUSCLE (version
3.8.31) (57) with the default settings. The nucleotide alignment was con-
structed by replacing each amino acid with the codon that gave rise to it.
Columns containing gaps in more than 1,000 of the 1,248 sequences were
removed. The genetic distance between HV species was subsequently es-
tablished using the published sequences in the alignment only, as de-
scribed previously (58), and a7% nucleotide difference (Hamming dis-
tance) was used to define HV clusters. PgHV sequences were then
segregated using hierarchical clustering, as implemented in the SciPy
package (59) using average linkage clustering.
Virus richness and sample estimation. We implemented models
from the biodiversity literature that utilize incidence distributions to es-
timate virus richness (number of unique viruses) and, hence, to estimate
the number of undetected viruses in the assemblage (60, 61). Incidence
data result where each virus detected in the assemblage is noted in each
sample as either present (verified detection) or absent (not detected,
which could result due to the virus being absent or being present but not
detected by the test, i.e., false absence).
From our samples, we first constructed virus accumulation and rar-
efaction curves for visualization. The asymptote of the rarefaction curve
provides the estimate of the number of viruses that characterizes the as-
semblage. However, sampling to reach this asymptote is impractical, as
the number of samples required may be prohibitively large (61). We thus
used statistical methods to estimate the asymptote from the data at hand.
We used the nonparametric asymptotic estimator, Chao2 (15, 10),
and also calculated ICE and Jackknife statistics for comparison. Unlike
conventional curve-fitting procedures, the nonparametric estimators
make no assumptions of an underlying abundance distribution, do not
require ad hoc or a priori model fitting, are relatively robust to spatial
autocorrelation and scale, and frequently outperform other methods of
richness estimation (61). They rely on the principle that the frequencies of
the rarest species in a set of samples can be used to estimate the frequencies
of undetected species and provide a minimum richness estimate.
All analyses were conducted with the fossil package (62) implemented
in R (63). We followed Chao et al. (10) to calculate how many additional
samples would be required to detect any proportion (including 100%) of
the asymptotic virus richness. All statistics were incorporated into a single
plot.
Cooccurrence. Patterns of association/disassociation were explored
with the Fortran software program PAIRS (11), utilizing the C score sta-
tistic as our measure of species cooccurrence. PAIRS implements a Bayes-
ian approach (Bayes M criterion) to detect nonrandom associations be-
tween pairs of species (12).
Assumptions and caveats We considered the detection and discovery
of viruses akin to the problem of detection and discovery of biodiversity,
as is frequently the goal of ecological studies. The basic mechanism of
species detection occurs from drawing samples by collection from some
larger assemblage (61). In this context, our samples are as described
above, urine, throat, fecal, or roost urine taken from an individual bat or
bat roost, which represent the biomes for our assemblage of interest.
These methods require the assemblage of viruses under sampling to be
closed for valid inference, that is, that the assemblage size and composi-
tion remained stable throughout the course of the study, an assumption
we felt was justified. Although each of these sample types targets a unique
biome of potential viral habitat from the host species, each with poten-
tially differing efficacy for detecting any given virus, for the purposes of
our analyses, we considered each sample a random and equivalent draw
from the assemblage of viruses associated with this host species. We also
assumed sample independence, even though multiple samples (e.g., urine
and throat) were often drawn from the same individual host and sampled
bat populations are likely to be geographically nonrandom. The conse-
quence of this sampling strategy is that our analysis is blind to this addi-
tional source of geographical variation and occasional pseudoreplication,
which means our virus accumulation results are specific to our sampling
methodology and our extrapolations assume ongoing sampling with a
similar average composition of samples. The results of additional analyses
in which we isolated sample types and individuals and considered geo-
graphic variation are not presented herein.
Nucleotide sequence accession numbers. The GenBank accession
numbers for viruses discovered in this study are KC692400 to KC692452.
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